StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish analyst view, supported by a target substantially above the posted price; treat as an opinion rather than a catalyst or guarantee.
What happened, with direct paths to the underlying reporting
Oppenheimer reiterated its Outperform rating on Compass Pathways with a $20 target versus the posted price of $8.59, implying substantial target-price upside. Analyst targets are opinions, not guarantees.
Target: $20
Posted price: $8.59
Analyst firm: Oppenheimer
Analyst: Francois Brisebois
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.